Nephron Clinical Practice · 2012 · 47 citations · 35 references
MedicineNephrologyPharmacotherapyDialysisHemodialysisRenal Replacement TherapyBlood Pressure ControlBlood Pressure ManagementChronic Kidney DiseaseHypertension ControlHypertension ManagementRenal DiseaseAntihypertensive TreatmentBlood PressureChronic Kidney Disease EpidemiologyChronic Kidney Disease ManagementChronic Kidney Disease Medication ManagementChronic Kidney Disease-related HypertensionHypertension In CkdHypertension In Kidney Disease
BACKGROUND/AIMS: Data on the prevalence, treatment and control of hypertension in patients with advanced chronic kidney disease (CKD) are limited. This study aimed to examine the above factors in a cohort of predialysis patients. METHODS: During a period of 4 months, we recorded information on blood pressure (BP), comorbidities, medications and related parameters of patients followed up in the Low-Clearance Clinic of our Department. Control rates of hypertension were calculated at two thresholds: <130/80 and <140/90 mm Hg. Univariate and multiple linear regression analyses were employed to assess factors associated with BP control. RESULTS: In the population studied [n = 238, males 58.4%, age 66.21 ± 4.2 years (mean ± SD), estimated glomerular filtration rate 14.5 ± 4.8 ml/min/1.73 m(2)], the prevalence of hypertension was 95.0%. Treatment rate among hypertensives was at 99.1%. On average, 3.04 ± 1.32 antihypertensive drugs were used, ranging from 1 to 7 agents. BP control rates at the <130/80 and <140/90 mm Hg thresholds were 26.5% and 48.2%, respectively. The systolic goal was achieved in 31.0% and 50.4%, whereas the diastolic goal was achieved in 67.7% and 91.2% of patients, respectively. In multivariate analysis, only black race was independently and inversely related with hypertension control (β = -0.187, p = 0.030). No specific antihypertensive class showed independent associations with control. CONCLUSIONS: Hypertension is highly prevalent in predialysis CKD patients. An almost universal treatment, employing a multi-agent regime, can help towards improved rates of control. Systolic BP is the main barrier to successful control and black race is associated with poorer control rates.
35
2013 ESH/ESC Guidelines for the management of arterial hypertension
Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz et al. · European Heart Journal · 2013 · 13.7K citations · Full text
2007 Guidelines for the Management of Arterial Hypertension
Giuseppe Mancia, Guy De Backer, Anna F. Dominiczak et al. · Journal of Hypertension · 2007 · 5.8K citations
Standards of Medical Care in Diabetes—2010
Diabetes Care · 2009 · 3.5K citations · Full text